DHR vs SLB: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and SLB N.V. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-10.
Danaher Corporation Β· Healthcare
$195.98
+7.9% upside to fair value
Grade B High Quality
VS
SLB N.V. Β· Energy
$48.09
-33.4% upside to fair value
Grade C
QuantHub Verdict
DHR has more upside to fair value (+7.9%). SLB trades at a lower forward P/E (21.8x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR SLB
Current Price $195.98 $48.09
Fair Value Estimate $211.54 $32.01
Upside to Fair Value +7.9% -33.4%
Market Cap $138.7B $71.9B
Forward P/E 37.8x 21.8x
EV / EBITDA 22.8x 10.9x
Price / Sales 5.6x 2.0x
Price / FCF 26.2x 15.4x
Revenue Growth YoY +3.7% +2.7%
Gross Margin 60.7% 17.3%
Operating Margin 21.0% 14.4%
Return on Equity 7.1% 13.5%
Dividend Yield 0% 0%
FCF Yield 3.81% 6.51%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
SLB β€” SLB N.V.
SLB N.V. is a global leader in oilfield services, specializing in well construction, production systems, reservoir performance, and digital solutions. The company benefits from a durable competitive moat anchored in technology, integrated service breadth, and global infrastructure, with a management team that has long tenure and deep industry experience. Despite solid free cash flow generation of…
Accumulation Zones
Metric DHR SLB
Zone Low $158.66 $24.01
Zone High $179.81 $27.21
In Buy Zone? No No
← DHR Research    SLB Research β†’    All Research